TORLEY HELEN (PRESIDENT AND CEO) sold 7.6% of their position (60K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $4.31M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+20K
Price / share
$8.11
Trade value
$162.20K
% of position
Common Stock
Shares
−11.71K
Price / share
$75.11
Trade value
$879.15K
% of position
Common Stock
Shares
−8.29K
Price / share
$75.69
Trade value
$627.87K
% of position
Common Stock
Shares
+20K
Price / share
$8.11
Trade value
$162.20K
% of position
Common Stock
Shares
−6.60K
Price / share
$70.51
Trade value
$465.36K
% of position
Common Stock
Shares
−10.20K
Price / share
$71.28
Trade value
$727.04K
% of position
Common Stock
Shares
−2.40K
Price / share
$72.06
Trade value
$172.96K
% of position
Common Stock
Shares
−700.00
Price / share
$73.24
Trade value
$51.27K
% of position
Common Stock
Shares
−100.00
Price / share
$74.67
Trade value
$7.47K
% of position
Common Stock
Shares
+20K
Price / share
$8.11
Trade value
$162.20K
% of position
Common Stock
Shares
−14.23K
Price / share
$68.47
Trade value
$974.70K
% of position
Common Stock
Shares
−2.33K
Price / share
$69.83
Trade value
$162.98K
% of position
Common Stock
Shares
−2.71K
Price / share
$70.58
Trade value
$191.07K
% of position
Common Stock
Shares
−724.00
Price / share
$71.67
Trade value
$51.89K
% of position
Net shares
+0.00
Net value
-$3.83M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2025 | M · Option Exercise | +20K | $8.11 | $162.20K | 2.7% | 733.72K | 753.72K |
| Common Stock Direct | 10/1/2025 | S · Sale | −11.71K | $75.11 | $879.15K | 1.6% | 753.72K | 742.01K |
| Common Stock Direct | 10/1/2025 | S · Sale | −8.29K | $75.69 | $627.87K | 1.1% | 742.01K | 733.72K |
| Common Stock Direct | 10/2/2025 | M · Option Exercise | +20K | $8.11 | $162.20K | 2.7% | 733.72K | 753.72K |
| Common Stock Direct | 10/2/2025 | S · Sale | −6.60K | $70.51 | $465.36K | 0.9% | 753.72K | 747.12K |
| Common Stock Direct | 10/2/2025 | S · Sale | −10.20K | $71.28 | $727.04K | 1.4% | 747.12K | 736.92K |
| Common Stock Direct | 10/2/2025 | S · Sale | −2.40K | $72.06 | $172.96K | 0.3% | 736.92K | 734.52K |
| Common Stock Direct | 10/2/2025 | S · Sale | −700.00 | $73.24 | $51.27K | 0.1% | 734.52K | 733.82K |
| Common Stock Direct | 10/2/2025 | S · Sale | −100.00 | $74.67 | $7.47K | 0.0% | 733.82K | 733.72K |
| Common Stock Direct | 10/3/2025 | M · Option Exercise | +20K | $8.11 | $162.20K | 2.7% | 733.72K | 753.72K |
| Common Stock Direct | 10/3/2025 | S · Sale | −14.23K | $68.47 | $974.70K | 1.9% | 753.72K | 739.48K |
| Common Stock Direct | 10/3/2025 | S · Sale | −2.33K | $69.83 | $162.98K | 0.3% | 739.48K | 737.15K |
| Common Stock Direct | 10/3/2025 | S · Sale | −2.71K | $70.58 | $191.07K | 0.4% | 737.15K | 734.44K |
| Common Stock Direct | 10/3/2025 | S · Sale | −724.00 | $71.67 | $51.89K | 0.1% | 734.44K | 733.72K |
| Total | +0.00 | -$3.83M | ||||||
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
8.11
Held after
116.57K
Exercisable
—
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
8.11
Held after
96.57K
Exercisable
—
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
8.11
Held after
76.57K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock20K shares | 10/1/2025 | M · Option Exercise | −20K | 8.11 | — | 116.57K |
| Option to Purchase Common Stock Direct | Common Stock20K shares | 10/2/2025 | M · Option Exercise | −20K | 8.11 | — | 96.57K |
| Option to Purchase Common Stock Direct | Common Stock20K shares | 10/3/2025 | M · Option Exercise | −20K | 8.11 | — | 76.57K |